medigraphic.com
Revista Médica Sinergia

2019, Number 06

<< Back Next >>

Revista Médica Sinergia 2019; 4 (06)

Approach to Bell’s paralysis: diagnosis and treatment

Saborío CIE, Villalobos BD, Bolaños PC

Language: Spanish
References: 16
Page: 81-89
PDF size: 403.13 Kb.


ABSTRACT

Bell’s palsy or peripheral facial paralysis is a neuromuscular disease with direct involvement of the facial nerve. It is a common pathology with presentation peaks at 20 to 29 years and 50 to 59 years. Although it is idiopathic, the herpes simplex virus is the main cause of suspicion. It is shown as a sudden unilateral facial paralysis with subsequent worsening. It presents symptoms such as muscular and sensitive nervous affectation like difficulty to raise the eyebrow, to close the eyes, to smile, to frown, facial paresthesias, hyperacusis, among others. Its diagnosis is mainly clinical, but other complementary diagnostic methods are also used to rule out various pathologies. It is necessary a prompt and timely management to achieve complete remission and avoid complications, this includes oral corticosteroids, assess the use of antivirals and an adequate eye protection. Most patients manifest spontaneous remission with a complete recovery, those who show an incomplete recovery can benefit from physical therapies to improve facial function and the prevention of sequelae such as hypertonicity, facial asymmetry and synkinesis.


REFERENCES

  1. Vakharia K, Vakharia K. Bell´s Palsy. Facial Plast Surg Clin North AM. 2016; 24(1): 1- 10.http://dx.doi.org/10.1016/j.fsc.2015.08.001

  2. Ronthal M. Bell’s palsy: Pathogenesis, clinical features, and diagnosis in adults [Internet]. Waltham: Uptodate; 2019 [consultado el 16 marzo 2019]. Disponible en:https://www.uptodate.com/contents/bellspalsy- pathogenesis-clinical-features-and-diagnosis-inadults? search=paralisis%20de%20bell&source=search_result&selectedTitle=2~150&usage_type=default &display_rank=2

  3. Walbaum B, Rada G. ¿Es útil agregar antivirales a los corticoides en la parálisis de Bell en adultos?. Medwave. 2015; 15(2): e6226. https://doi:10.5867/medwave.2015.6226

  4. Sánchez M, Catacolí J, Echandía C, Zapata J. Evaluación del índice clínico de función del nervio facial en pacientes con parálisis de Bell. Rev Col Med Fis Rehab. 2016; 26(2): 155-161. Disponible en: http://www.revistacmfr.org/index.php/rcmfr/article/view/163

  5. Mendoza A, Pereda M, Hernández M, Peña A. Tratamiento con acupuntura en pacientes afectados por parálisis facial periférica. Correo Científico Médico. 2015; 19(3): 441-452. Disponible en: http://scielo.sld.cu/scielo.php?pid=S1560-43812015000300006&script=sci_arttext&tlng=pt

  6. Eviston T, Croxson G, Kennedy P, Hadlock T, Krishnan A. Bell’s palsy: aetiology, clinical features and multidisciplinary care. J Neurol Neurosurg Psychiatry. 2015; 86(12): 1356-1361.http://doi:10.1136/jnnp- 2014-309563

  7. Holland J, Bernstein J. Bell’s palsy. BMJ Clin Evid. 2014; 2014: 1204.

  8. Ferrera T, Hernández M, Castro L, Castro V. Evaluación clínica y funcional de pacientes con parálisis de Bell tratados con láser. MEDISAN. 2015; 19(12): 1459-1465. Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192015001200004

  9. Álvarez C, Mora N, González R. Parálisis facial periférica: Enfoque desde la medicina Física y rehabilitación en Costa Rica. Revista Médica de Costa Rica y Centroamérica. 2015; 72(615): 249-255. Disponible en: http://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=66090

  10. Payá A, Navarro R, Climent I, Redondo M. Parálisis facial periférica recurrente y alternante en un servicio de Rehabilitación. Rehabilitación. 2019; 53(1): 60-64.https://doi.org/10.1016/j.rh.2018.06.001

  11. Phan N, Panizza B, Wallwork B. A general practice approach to Bell’s palsy. Australian Family Physician. 2016; 45(11): 794-797. Disponible en: https://www.racgp.org.au/afp/2016/november/a-general-practiceapproach- to-bell%E2%80%99s-palsy/

  12. Somasundara D, Sullivan F. Management of Bell’s palsy. Aust Prescr . 2017; 40(3): 94-97. http://dx.doi.org/ 10.18773/austprescr.2017.030

  13. Ríos S. Electroestimulación muscular selectiva utilizada en el tratamiento kinésico de pacientes con parálisis facial periférica aguda y crónica. Rev. Fac. Med. UNNE. 2016; 36(1): 43-47. Disponible en: http://revistas.unne.edu.ar/index.php/rem/article/view/2428

  14. Benítez S, Danilla S, Troncoso E, Moya A, Mahn J. Manejo integral de la parálisis facial. Rev. Med. Clin. Conde. 2016; 27(1): 22-28. https://doi.org/10.1016/j.rmclc.2016.01.004

  15. Ronthal M. Bell’s palsy: Treatment and prognosis in adults [Internet]. Waltham: Uptodate; 2019 [consultado el 17 marzo 2019]. Disponible en: https://www.uptodate.com/contents/bells-palsy-treatmentand- prognosis-in adults?search=paralisis%20de%20bell&source=search_result&selectedTitle=1~150&usage_type=default &display_rank=1

  16. Afrashtehfara C, Afrashtehfara K. Corrección de la sonrisa con toxina botulínica en un paciente con parálisis facial. Rev. Fac. Med. 2015; 58(4): 34-38. Disponible en:http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0026-17422015000400034




2020     |     www.medigraphic.com